chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Continuous fever of 102 degree; Dose received: 3; This is a spontaneous report from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 38-year-old male patient received bnt162b2 (COVID-19 VACCINE - MANUFACTURER UNKNOWN), administered in left arm, administration date 06Jan2022 at 17:00 (Lot number: unknown) at the age of 38 years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine manufacture unknown (DOSE 1; MANUFACTURER UNKNOWN, Lot Number: UNKNOWN, Anatomical Location: Left arm, Administration time: 12:00), administration date: 29Mar2021, when the patient was 37 years old, for COVID-19 immunisation and Covid-19 vaccine manufacture unknown (DOSE 2; MANUFACTURER UNKNOWN, Lot Number: UNKNOWN, Anatomical Location: Left arm, Administration time: 11:00), administration date: 19Apr2021, when the patient was 37 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 06Jan2022 at 17:00, outcome "unknown", described as "Dose received: 3"; PYREXIA (non-serious) with onset 07Jan2022 at 12:00, outcome "not recovered", described as "Continuous fever of 102 degree". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia.  Additional Information: The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not got fever for the last two doses. Therapeutic measures taken as a result of the continuous fever of 102 degree included treatment with just Tylenol.   The lot number for BNT162b2 was not provided and will be requested during follow up.
OFF LABEL USE; INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTERED; This spontaneous report received from a patient concerned an elderly female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: stiff, and hurting. The patient was previously treated with adalimumab for moderate to severe rheumatoid arthritis. The patient was previously received covid-19 vaccine ad26.cov2.s (Dose umber in series: 1) (suspension for injection, intramuscular, batch number: Unknown and expiry: Unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. Following vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced feeling unwell, pain and stiffness (Dose umber in series: 1). The patient recovered from feeling unwell, pain and stiffness. The patient was previously received covid-19 vaccine ad26.cov2.s (Dose umber in series: 2) (suspension for injection, intramuscular, batch number: Unknown and expiry: Unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. No adverse events were reported following vaccination with covid-19 vaccine ad26.cov2.s (Dose umber in series: 2). The patient received covid-19 vaccine ad26.cov2.s (Dose umber in series: 3) (suspension for injection, intramuscular, batch number: Unknown and expiry: Unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination which is off label use, and inappropriate schedule of vaccine administered (Dose umber in series: 3). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the off label use and inappropriate schedule of vaccine administered was not reported. This report was non-serious. This case, involving the same patient is linked to 20220304173 (Dose umber in series: 1).
Severe excruciating pain in right arm, shoulder and hand. Swollen hand and fingers. Heart palpitations and hyperventilating. Unable to sleep. Loss of appetite. Unable to dress and undress self and perform daily personal hygiene.
Sharp, stabbing aches and pains that come and go every minute throughout whole body, mostly in stomach and chest but also feet, arms, and legs. Started 5/30/21 and has been occurring for 8 days.
Full body rash came on suddenly - put child to bed on 6/5/19 with no visible symptoms, upon waking 6/6/19 child had a full body rash. Child was taken back to the doctor's office that provided the vaccine, parents were advised this was an adverse reaction to the MMR vaccine the child had received on 5/29/19. The child was sent to daycare where the child ate and slept as per her normal routine. The child refused food at 5 PM for parents that day and went to bed earlier than normal (approx. 5:30 PM, child normally goes to bed at 6 PM). Ibuprofen 1.875 ML was administered to child at approx. 5:30 PM.  The following morning the rash was greatly improved. The child went to day care, continued to eat normally at the facility. Parents were called at 3 PM, informed child at a fever of 103.5. Parents called the doctor's office, was told this too was an adverse reaction to vaccine and to continue to monitor. Ibuprofen was administered at approx. 4 PM. Child went to sleep at approx. 5:30 PM.  6/8/19 the rash was gone. No fever. Child was more groggy than normal. Child refused solid foods. Parents bottle fed (formula) all day. Child awoke approximately every 2 hours for feeding and went back to sleep. 6/9/19 No rash and no fever. Child continued to refuse solid foods. The same pattern was previous day.  6/10/19 Child went to daycare facility. Ate solid foods and napped as usual. Normal pattern resumed - with the exception that child was more tired that usual upon arriving home 6/10/19 through 6/13/19.
enlarged lymph nodes; Swelling in his left arm; This case was reported by a other health professional via call center representative and described the occurrence of enlargement of lymph nodes in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th January 2020, the patient received the 2nd dose of Shingrix .5 ml. On 17th January 2020, 4 days after receiving Shingrix, the patient experienced enlargement of lymph nodes and swelling arm. On an unknown date, the outcome of the enlargement of lymph nodes and swelling arm were recovering/resolving.   It was unknown if the reporter considered the enlargement of lymph nodes and swelling arm to be related to Shingrix.  Additional details were received as follows: The reporter stated that the patient received a second dose of the vaccine and experienced swelling in his left arm. The reporter stated that an ultrasound showed 2 enlarged lymph nodes. The patient returned on the day of reporting and the swelling had reduced. The reporter consented to follow up.
Patient was initially seen on 4/16 in the ED and discharged after complaints of myalgias.  She was tested for COVID and discharged home and instructed to take acetaminophen.  On 4/20, she returned to the ED with continued complaints including abdominal pain, nausea, and diarrhea.  She also complained of dizziness when she stands, and that her skin and eyes were jaundiced.  The patient was hypotensive and was not responding to IV fluids.  She was started on vasopressors.  She was found to be in acute liver and kidney failure.  She was emergently intubated and ended up being transferred to hospital.  Due to the nature of her condition, the above therapies were continued and CRRT was started due to acidosis.  A bicarb drip was started and was continuous.  Arrangements were made to transfer the patient to hospital once stable enough.  It was thought that she was in HLH.  She was also empirically started on hydrocortisone, later changed to dexamethasone.  She was started on antibiotics - cefepime, Flagyl, and vancomycin. She has now been transferred to hospital.  Outcome unknown at this time.  4/22
Radial nerve paralysis right arm onset 3/13/07. Right wrist drop with decrease ROM and strength. Treated with Deltazone 10 mg. 03/16/07-records received for 3/9 and 3/14/07 DOS on 3/9/07 received vaccine in right deltoid. History of present illness documents patient crawling through fence and got splinter in back of left shoulder. Splinter and splinter pieces removed from shoulder area. Required 10 sutures.   Returned on 3/14/07 with complaint of right upper arm numbness. Unable to move hand passively, laterally or back of hand to wrist in an extension movement.  PE:erythema at suture site on left shoulder. decreased strength in right hand grip. Decreased range of motion laterally. Positive brisk cap refill. Impression:right wrist drop radial nerve paralysis Per information from annual follow up, pt stated on 12/5/07 that radial nerve palsy had improved with strength, but still has some numbness.
post vaccine patient complained of dizziness, had an extra 15 minutes of rest, felt no better and complained she felt out of it.
Immediately became dizzy and flushed. Had moderate vertigo for approximately 30 mins. Two hrs later, both feet became painful, tingly, and turned reddish purple. This has been intermittent and still occurs. Thame same evening noticed random hot flashes, full body redness, flushing, and excessive sweating. Have not had a menstrual period since first dose, but have frequent uterine cramping. Increased GERD and intestinal symptoms. Brain fog, memory issues, insomnia, anxiety, and depression. Bilateral Hand/wrist arthritic type pain, and nerve pain, as well as decreased ROM and difficulty with daily ADLs.
8 days post vaccination, patient reports itching with redness, heat and induration at the site of vaccination.  Felt like a "bee sting."  Resolved without treatment by 1/2/21.
Some 6 hours after the booster shot, I experienced severe muscle pain, joint pain, chills and fever for the next 24  hours. It was worse than the symptoms experienced after the first 2 shots of Moderna.
History of chicken pox as a child in 1991. Received varicella vaccine 1/3/07 per college requirements. Broke out in multiple head to toe pox starting 1/6/07.  Pox in throat and fever of 101 degrees on 1/8/07. 1/12/07-Seen by PCP with negative strep throat screen. 1/14/07-C/O earache. 1/15/07-Seen again by PCP who noted pox on eardrum with exam.
Mom called and reports has a red, raised knot on left thigh, size of golf ball. It sore and limping. Denies fever, has tried TYLENOL and MOTRIN. Mom states MOTRIN helped some. 5/22/13 called mom site doing fine.
Patient received dose of vaccine on right deltoid at 4:09PM at around 4:23PM developed symptoms. Symptoms described as: feeling "warmth, like if feels when you take NAICIN-flushing sensation but only minor". Other symptoms includes light rash in both arms,  redness on face and arms. Excluding back, trunk and legs. Patient denies sore throat, swelling or tingling of tongue or mouth, lips. Denies drooling, no difficulty swallowing. Denies chest pain, SOB, palpitations, dizziness or light headed. No near syncope episodes.  Patient refused Benadryl due to driving alone and also refused EMS to transport to ER.
Patient with chills and wheezing.  Pt says she is a very active person and doesn't like to sit down. The patient was brought back to the provider tent and examined. BP 154/93 P 73 RR 18 PO2 99% RA. Patient was provided water and cookie but refused.
Information has been received from a consumer concerning her 19 month old daughter with no allergies or medical history who on approximately 01/18/2003 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # not reported).  There were no concomitant medications.  Subsequently, the patient experienced thrombocytopenia.  Laboratory evaluation revealed that the patient's platelet levels dropped to 6,000 (normal values not reported).  The patient was admitted to inpatient hospitalization for three days.  Additional information has been requested.
This spontaneous report was received from a physician via a company representative refers to a patient of unknown age. On an unknown date the patient was vaccinated with M-M-R II (dose, route, frequency, lot # unspecified). No concomitant medications were reported. The physician reported to the field representative that 2 hours after receiving the M-M-R II , the unspecified baby (age unspecified) patient experienced an episode of vomiting. The field representatie stated, the baby's mother said she won't be vaccinating her child with any more vaccines because her baby always has a reaction after receiving a vaccine. The field representative could not provide any further information regarding the unspecified baby patient reactions to other unspecified vaccines. The unspecified patient's mother called the physician. Action taken was not applicable (also reported as therapy stopped). The outcome of vomiting was unknown. Additional information has been requested.
About a week after the vaccine I started feeling fatigued and throughout the day I had to take a nap every hour or less. I started having neck pain and intercostal - muscle between ribs - pain. Went to PCP I got an abnormal EKG and went to cardiologist and got another abnormal EKG and then needed a ultrasound but it was normal. Was gradually recovering. Decided not to have the cardiac MRI. Major symptoms: severe fatigue and muscle pain.
04/22/2021- 03:00PM- I wasn't feeling well and had a low grade fever, I wasn't concerned at the time but fever it lasted until May 15, 2021; 04/30/2021- I could get out of the bed and I was nausea.
This is a spontaneous report from a contactable consumer (son) reported for his mother. A 76-years-old female patient received PREVNAR 13, via an unspecified route of administration on 22Oct2015 at 0.5 ml, single. Medical history included ongoing fibromyalgia and osteoarthritis diagnosed years ago. The patient's concomitant medications were not reported. The patient experienced kidney infection on 12Jan2016 with outcome of recovered a rheumatologist did a culture and provided her antibiotics. In Oct2015 the patient got a cold, fever with outcome of recovered and chills with outcome of recovering. The patient also experienced sore body/ soreness all over, trouble walking, swelling in arms, elbow, neck, wrist, stomach, hands, shoulders, legs and feet/ her hands and feet are swollen, can't dress herself in Oct2015 with outcome of not recovered, muscle and joint aches and pains, was told that the shot aggravated fibromyalgia and she can't sleep in the bed on an unspecified date with outcome of unknown. Had rash in Jan2016 with outcome of recovering. The patient began experiencing a majority of these events about a week and a half after receiving the PREVNAR 13 injection. Reporter took the patient to the emergency room where they ran blood tests because she was crying in pain and they told him nothing was wrong, and her events were probably because of the PREVNAR 13 shot. The patient went to her doctor regarding these events, on two occasions. The first visit the doctor did not find anything wrong. The second visit the doctor told her it was probably from the shot, but there was nothing they could do about it now. The patient underwent lab tests and procedures which included blood electrolytes that was fine, blood test: nothing was wrong, and culture: kidney infection, on an unknown date.
A non-serious, spontaneous report of administered expired FLUMIST was received from a other health professional concerning a five-year-old male. Neither medical history nor concomitant medications were provided. The product expired on 12-Dec-2010. On 13-Dec-2010, the patient received expired product. there was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. Additional information was received on 14-Feb-2011: Reporter confirmed that there was no late occurrence of adverse events.
C/O itchy Rt hand-site of wk stamp. Rx-observation x 15".
Itchiness; Arm Swelling (right); Tenderness (right); Arm pinkish in color; Rashes on elbow (right); Arm soreness  (right); Third dose given more than 35 days from second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS, PERIPHERAL SWELLING (right arm), TENDERNESS, ERYTHEMA, and RASH (right elbow) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 022C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Aug-2021, the patient experienced PRURITUS, PERIPHERAL SWELLING (right arm), TENDERNESS, ERYTHEMA, RASH (right elbow), MYALGIA (right arm), and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Third dose given more than 35 days from second dose). At the time of the report, PRURITUS, PERIPHERAL SWELLING (right arm), TENDERNESS, ERYTHEMA, RASH (right elbow), MYALGIA (right arm), and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Third dose given more than 35 days from second dose) had resolved.            No concomitant medication were provided by the reporter.  No treatment medication were provided by the reporter.
Pain, redness, swelling, and heat at injection site. Reduced effects with Tylenol. Hives approx 6-8 hours after injection. Rash near site due to adhesive allergy reaction. Hives and rash resolved after taking Benadryl for 2 nights in a row beginning the night vaccine received. New symptoms began 4 days after receiving vaccine; fever/chills, body aches, malaise. They resolved approximately 3 days later. Mild pain, redness, swelling, and heat at injection site increased to moderate status 8 days following vaccination. At 9 days following vaccination a telehealth appointment determined cellulitis at the injection site.
MMR Vaccine leaked out from the connection point between the needle and the syringe while administering the MMR vaccine
Patient started to experience chest pain, difficulty breathing, and light-headedness approximately 5 minutes after receiving their first dose of the Pfizer COVID-19 vaccine.  10-15 minutes after dose administration, patients blood pressure was 108/56 mmHg which they stated was normal for them. I continued to observe and a few minutes later the patient stated their chest pain and light-headedness was worsening. I called 911 emergency personnel at 17:40 to the scene for further care, they arrived at 17:48 and took him to the hospital for evaluation.
Pfizer-BioNTech COVID-19 Vaccine EUA:  patient in clinic for follow-up of optic neuritis and neuromyelitis optica flare. Managed with intermittent IV steroids and inebilizumab-cdon (Uplinza).
chills; kidney soreness; body aches; muscle cramps; joint pain; Injection site swelling andd redness; Injection site swelling andd redness; Injection site swelling andd redness; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves Adult male patient who experienced chills, kidney soreness, body aches, muscle cramps, joint pain and injection site swelling andd redness, while he received vaccine DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (TDap).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a Dose of suspect DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE produced by unknown manufacturer lot number not reported.  The patient developed a non-serious chills, kidney soreness, body aches, muscle cramps, joint pain and injection site swelling and redness (Unknown latency) following the administration of DIPHTHERIA and TETANUS AND ACELLULAR PERTUSSIS VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was vaccination site inflammation, joint pain, muscle cramps, body aches, kidney soreness and chills.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for all the events.  Information on the batch number was requested.  List of documents held by the sender: none
A little tired; Arm was sore; COVID-19 positive test; Drug ineffective; This spontaneous case was reported by a patient and describes the occurrence of SARS-COV-2 TEST POSITIVE (COVID-19 positive test), DRUG INEFFECTIVE (Drug ineffective), FATIGUE (A little tired) and MYALGIA (Arm was sore) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 025A21A) for COVID-19 vaccination.     The patient's past medical history included CLL.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Aug-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID-19 positive test) and DRUG INEFFECTIVE (Drug ineffective). On an unknown date, the patient experienced FATIGUE (A little tired) and MYALGIA (Arm was sore). At the time of the report, SARS-COV-2 TEST POSITIVE (COVID-19 positive test), DRUG INEFFECTIVE (Drug ineffective), FATIGUE (A little tired) and MYALGIA (Arm was sore) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Aug-2021, SARS-CoV-2 test: positive (Positive) Positive.         The patient tested positive for covid after getting two doses of vaccine. Treatment medication was  not reported. Relevant concomitant medications were not provided by the reporter.  Company Comment: Based on the mechanism of action of mRNA-1273, the event COVID-19 Positive test is assessed as not related to mRNA-1273, however, based on the current available information and temporal association between the use of the product and the start date of the remaining events, a causal relationship cannot be excluded.; Sender's Comments: Based on the mechanism of action of mRNA-1273, the event COVID-19 Positive test is assessed as not related to mRNA-1273, however, based on the current available information and temporal association between the use of the product and the start date of the remaining events, a causal relationship cannot be excluded.
loss of appetite and abdominal pains/spasms Narrative: unknown if related to vaccine but employee states: he has had a loss of appetite and abdominal pain/spasms for the past 4 days
Shortly after my first Covid vaccine on 7/3/21, I began to have loud ringing in my ears.   It?s been nonstop since the vaccine.   Sometimes it?s very loud and upsetting.  Nothing seems to alleviate except keeping background noise going helps distract me from it.